Active ingredient
Tirzepatide
54 finished FDA listings contain Tirzepatide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TIRZEPATIDE
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 2
- Strengths listed
- 10 mg/.5ml · 12.5 mg/.5ml · 12.5 mg/ml · 15 mg/.5ml · 16.7 mg/ml · 2.5 mg/.5ml · 20.8 mg/ml · 25 mg/ml · 4.17 mg/ml · 5 mg/.5ml · 7.5 mg/.5ml · 8.33 mg/ml
- Brand names in FDA listings
- Mounjaro, Mounjaro Kwikpen, Zepbound, Zepbound Kwikpen
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2601723
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 215866 | ELI LILLY AND CO | 2022-05-13 | 30 |
| NDA 217806 | ELI LILLY AND CO | 2023-11-08 | 24 |
Official labeling on DailyMed
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION MOUNJARO KWIKPEN (TIRZEPATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] · version 40 · 2026-09-02
- ZEPBOUND (TIRZEPATIDE) INJECTION, SOLUTION ZEPBOUND (TIRZEPATIDE) INJECTION, SOLUTION ZEPBOUND KWIKPEN (TIRZEPATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] · version 40 · 2026-09-02
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
- MOUNJARO (TIRZEPATIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] · version 1 · 2026-07-30
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.